259 related articles for article (PubMed ID: 9792543)
21. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.
Shah P; Vella A; Basu A; Basu R; Adkins A; Schwenk WF; Johnson CM; Nair KS; Jensen MD; Rizza RA
Diabetes; 2002 Feb; 51(2):301-10. PubMed ID: 11812736
[TBL] [Abstract][Full Text] [Related]
22. Impact of lack of suppression of glucagon on glucose tolerance in humans.
Shah P; Basu A; Basu R; Rizza R
Am J Physiol; 1999 Aug; 277(2):E283-90. PubMed ID: 10444424
[TBL] [Abstract][Full Text] [Related]
23. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene.
Surmely JF; Guenat E; Philippe J; Dussoix P; Schneiter P; Temler E; Vaxillaire M; Froguel P; Jéquier E; Tappy L
Diabetes; 1998 Sep; 47(9):1459-63. PubMed ID: 9726235
[TBL] [Abstract][Full Text] [Related]
24. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
[TBL] [Abstract][Full Text] [Related]
25. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
Mevorach M; Giacca A; Aharon Y; Hawkins M; Shamoon H; Rossetti L
J Clin Invest; 1998 Aug; 102(4):744-53. PubMed ID: 9710443
[TBL] [Abstract][Full Text] [Related]
26. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration.
Katz H; Homan M; Jensen M; Caumo A; Cobelli C; Rizza R
Diabetes; 1994 Feb; 43(2):289-96. PubMed ID: 8288053
[TBL] [Abstract][Full Text] [Related]
27. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
28. Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes.
Hawkins M; Gabriely I; Wozniak R; Vilcu C; Shamoon H; Rossetti L
Diabetes; 2002 Mar; 51(3):606-14. PubMed ID: 11872657
[TBL] [Abstract][Full Text] [Related]
29. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.
Roden M; Stingl H; Chandramouli V; Schumann WC; Hofer A; Landau BR; Nowotny P; Waldhäusl W; Shulman GI
Diabetes; 2000 May; 49(5):701-7. PubMed ID: 10905476
[TBL] [Abstract][Full Text] [Related]
30. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles.
Vella A; Reed AS; Charkoudian N; Shah P; Basu R; Basu A; Joyner MJ; Rizza RA
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E25-30. PubMed ID: 12637258
[TBL] [Abstract][Full Text] [Related]
31. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
Shiota M; Galassetti P; Monohan M; Neal DW; Cherrington AD
Diabetes; 1998 Jun; 47(6):867-73. PubMed ID: 9604861
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
Egan JM; Meneilly GS; Habener JF; Elahi D
J Clin Endocrinol Metab; 2002 Aug; 87(8):3768-73. PubMed ID: 12161508
[TBL] [Abstract][Full Text] [Related]
33. Assessment of hepatic insulin action in obese type 2 diabetic patients.
Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
[TBL] [Abstract][Full Text] [Related]
34. Comparison of insulin-mediated and glucose-mediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects.
Hansen IL; Cryer PE; Rizza RA
Diabetes; 1985 Aug; 34(8):751-5. PubMed ID: 3894118
[TBL] [Abstract][Full Text] [Related]
35. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
Banarer S; McGregor VP; Cryer PE
Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
[TBL] [Abstract][Full Text] [Related]
36. Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function.
Di Mauro M; Papalia G; Le Moli R; Nativo B; Nicoletti F; Lunetta M
Diabetes Res Clin Pract; 2001 Jan; 51(1):45-50. PubMed ID: 11137181
[TBL] [Abstract][Full Text] [Related]
37. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.
Shah P; Vella A; Basu A; Basu R; Schwenk WF; Rizza RA
J Clin Endocrinol Metab; 2000 Nov; 85(11):4053-9. PubMed ID: 11095432
[TBL] [Abstract][Full Text] [Related]
38. Glucose resistance contributes to diabetes mellitus in cirrhosis.
Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
[TBL] [Abstract][Full Text] [Related]
39. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
[TBL] [Abstract][Full Text] [Related]
40. Effects of recombinant human IGF-I on glucose and leucine kinetics in men.
Elahi D; McAloon-Dyke M; Fukagawa NK; Sclater AL; Wong GA; Shannon RP; Minaker KL; Miles JM; Rubenstein AH; Vandepol CJ
Am J Physiol; 1993 Dec; 265(6 Pt 1):E831-8. PubMed ID: 8279537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
